Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells.
about
HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory DiseasesInterconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemiaInactivation of LEF1 in T-cell acute lymphoblastic leukemia.Proteomic analysis identifies differentially expressed proteins after HDAC vorinostat and EGFR inhibitor gefitinib treatments in Hep-2 cancer cells.Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights.Synthesis and biological evaluation of triazol-4-ylphenyl-bearing histone deacetylase inhibitors as anticancer agentsHistone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies.Metabolism as a key to histone deacetylase inhibition.Investigational histone deacetylase inhibitors for non-Hodgkin lymphomas.Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect.Role of the histone H3 lysine 9 methyltransferase Suv39 h1 in maintaining Epsteinn-Barr virus latency in B95-8 cells.c-FLIP degradation mediates sensitization of pancreatic cancer cells to TRAIL-induced apoptosis by the histone deacetylase inhibitor LBH589.Late-Stage C-H Coupling Enables Rapid Identification of HDAC Inhibitors: Synthesis and Evaluation of NCH-31 AnaloguesAnalysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells.Gene expression studies demonstrate that the K-ras/Erk MAP kinase signal transduction pathway and other novel pathways contribute to the pathogenesis of cumene-induced lung tumors.
P2860
Q26739120-745909D5-7A64-4980-8ED4-09602D1F5908Q33706334-7950BE21-8BAE-46DD-A47F-AE6A37D66228Q33788690-57ECAEF5-64ED-4036-B8FC-5AD98DAB7231Q33962243-4E5B6986-4642-46AD-A363-35B866158D35Q33983255-4AE97296-9066-4363-B75E-C1F6A8F2DEB0Q34055631-130BFD0F-737D-4F62-BF9E-70115EC9FD20Q34399444-B01DB951-C914-4E76-91FC-ED874BDE2670Q35661981-B7B508E4-83F0-4356-A100-2031D2DA8FDBQ37774667-7541D889-A5A6-4A7C-A03B-4FBA9ED54410Q37821337-CB8A6852-F529-403A-B0E2-4B20F856821EQ39019130-D25FB2CC-8F25-41EA-ACC4-9699FE0EE34DQ39707590-73253DFB-FD38-4A80-B6A6-25D69A0EF984Q39785711-2D8A6FAC-E6A8-4FEB-9F09-5355F47B17E1Q40468248-32462815-9D97-489C-9671-7DA90A231E01Q46468224-828E4F51-2DC1-454A-AB23-1361499205FE
P2860
Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Proteome analyses of the growt ...... , on lymphoid malignant cells.
@en
type
label
Proteome analyses of the growt ...... , on lymphoid malignant cells.
@en
prefLabel
Proteome analyses of the growt ...... , on lymphoid malignant cells.
@en
P2093
P356
P1433
P1476
Proteome analyses of the growt ...... , on lymphoid malignant cells.
@en
P2093
Kayukawa S
Nakagawa H
Oshizawa T
P2888
P304
P356
10.1038/SJ.LEU.2404902
P577
2007-08-09T00:00:00Z
P5875
P6179
1017649861